{"id":1415,"date":"2018-09-24T20:05:27","date_gmt":"2018-09-24T20:05:27","guid":{"rendered":"https:\/\/touchrespiratory.com\/media_gallery\/arschang-valipour-ers-2018-endobronchial-treatment-for-chronic-bronchitis\/"},"modified":"2019-03-20T18:18:35","modified_gmt":"2019-03-20T18:18:35","slug":"arschang-valipour-ers-2018-endobronchial-treatment-for-chronic-bronchitis","status":"publish","type":"media_gallery","link":"https:\/\/touchrespiratory.com\/bronchitis\/conference-hub\/arschang-valipour-ers-2018-endobronchial-treatment-for-chronic-bronchitis\/","title":{"rendered":"Arschang Valipour, ERS 2018 \u2013 Endobronchial treatment for chronic bronchitis"},"content":{"rendered":"<p><b>Arschang Valipour<\/b> (Otto-Wagner-Spital, Wien, Austria) discusses the background and findings of his late-breaking presentation entitled: First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB).<\/p>\n<p>Questions<\/p>\n<p>1. What are the major unmet needs of patients with chronic bronchitis? (0:12)<br \/>\n2. What is the rationale for the ablation of mucus-producing airway cells in patients with chronic bronchitis? (0:48)<br \/>\n3. How is bronchial rheoplasty performed? (1:20)<br \/>\n4. Could you tell us a little about the first-in-human study you are presenting and its findings? (2:01)<br \/>\n5. Which patients are likely to benefit most from this procedure? (2:44)<\/p>\n<p>Speaker disclosure: Arschang Valipour has nothing to disclose in relation to this video interview.<\/p>\n<p><b>Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Arschang Valipour (Otto-Wagner-Spital, Wien, Austria) discusses the background and findings of his late-breaking presentation entitled: First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB). Questions 1. What are the major unmet needs of patients with chronic bronchitis? (0:12) 2. What is the rationale for the ablation of mucus-producing airway cells in patients [&hellip;]<\/p>\n","protected":false},"featured_media":1661,"template":"","class_list":["post-1415","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-bronchitis","video_categories-ers-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/1415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":0,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media_gallery\/1415\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media\/1661"}],"wp:attachment":[{"href":"https:\/\/touchrespiratory.com\/wp-json\/wp\/v2\/media?parent=1415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}